Houben R, Esmail H, Cobelens F, Williams CML, Coussens AK (2022) Tuberculosis prevalence: beyond the tip of the iceberg. Lancet Respir Med 10:537–539

Article  PubMed  Google Scholar 

World Health Organization (2022) Global tuberculosis report 2022. World Health Organization, Geneva

Google Scholar 

Visca D, Ong CWM, Tiberi S, Centis R, D’Ambrosio L, Chen B, Mueller J, Mueller P, Duarte R, Dalcolmo M, Sotgiu G, Migliori GB, Goletti D (2021) Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology 27:151–165

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, Falzon D, Floyd K, Gargioni G, Getahun H, Gilpin C, Glaziou P, Grzemska M, Mirzayev F, Nakatani H, Raviglione M, for WsGTBP (2015) WHO’s new end TB strategy. Lancet 385:1799–1801

Article  PubMed  Google Scholar 

Calligaro GL, Zijenah LS, Peter JG, Theron G, Buser V, McNerney R, Bara W, Bandason T, Govender U, Tomasicchio M, Smith L, Mayosi BM, Dheda K (2017) Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicentre randomised controlled trial. Lancet Infect Dis 17:441–450

Article  PubMed  Google Scholar 

Nguyen TNA, Anton-Le Berre V, Banuls AL, Nguyen TVA (2019) Molecular diagnosis of drug-resistant tuberculosis; a literature review. Front Microbiol 10:794

Article  PubMed  PubMed Central  Google Scholar 

Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J (2010) Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375:1830–1843

Article  PubMed  Google Scholar 

Liu D, Huang F, Zhang G, He W, Ou X, He P, Zhao B, Zhu B, Liu F, Li Z, Liu C, Xia H, Wang S, Zhou Y, Walker TM, Liu L, Crook DW, Zhao Y (2022) Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China. Clin Microbiol Infect 28:731 e9-731 e15

Article  PubMed  Google Scholar 

Kato-Maeda M, Metcalfe JZ, Flores L (2011) Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol 6:203–216

Article  CAS  PubMed  Google Scholar 

Nikolayevskyy V, Kranzer K, Niemann S, Drobniewski F (2016) Whole genome sequencing of Mycobacterium tuberculosis for detection of recent transmission and tracing outbreaks: A systematic review. Tuberculosis (Edinb) 98:77–85

Article  CAS  PubMed  Google Scholar 

Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, Farhat MR, Guthrie JL, Laukens K, Miotto P, Ofori-Anyinam B, Dreyer V, Supply P, Suresh A, Utpatel C, van Soolingen D, Zhou Y, Ashton PM, Brites D, Cabibbe AM, de Jong BC, de Vos M, Menardo F, Gagneux S, Gao Q, Heupink TH, Liu Q, Loiseau C, Rigouts L, Rodwell TC, Tagliani E, Walker TM, Warren RM, Zhao Y, Zignol M, Schito M, Gardy J, Cirillo DM, Niemann S, Comas I, Van Rie A (2019) Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues. Nat Rev Microbiol 17:533–545

Article  CAS  PubMed  Google Scholar 

Pang Y, Zhou Y, Zhao B, Liu G, Jiang G, Xia H, Song Y, Shang Y, Wang S, Zhao YL (2012) Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS ONE 7:e32976

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu X, Shang Y, Ren W, Wang W, Wang Y, Xue Z, Li S, Pang Y (2022) Minimum inhibitory concentration of cycloserine against Mycobacterium tuberculosis using the MGIT 960 system and a proposed critical concentration. Int J Infect Dis 121:148–151

Article  CAS  PubMed  Google Scholar 

Du J, Li Q, Liu M, Wang Y, Xue Z, Huo F, Zhang X, Shang Y, Li S, Huang H, Pang Y (2021) Distinguishing relapse from reinfection with whole-genome sequencing in recurrent pulmonary tuberculosis: a retrospective cohort study in Beijing. China Front Microbiol 12:754352

Article  PubMed  Google Scholar 

Meehan CJ, Moris P, Kohl TA, Pecerska J, Akter S, Merker M, Utpatel C, Beckert P, Gehre F, Lempens P, Stadler T, Kaswa MK, Kuhnert D, Niemann S, de Jong BC (2018) The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology. EBioMedicine 37:410–416

Article  PubMed  PubMed Central  Google Scholar 

Yu Q, Su Y, Lu B, Ma Y, Zhao X, Yang X, Dong H, Liu Y, Lian L, Wan L, Wu Y, Wan K (2013) Genetic diversity of Mycobacterium tuberculosis isolates from Inner Mongolia. China PLoS One 8:e57660

Article  CAS  PubMed  Google Scholar 

Parwati I, van Crevel R, van Soolingen D (2010) Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 10:103–111

Article  PubMed  Google Scholar 

Duan Q, Zhang Z, Tian D, Zhou M, Hu Y, Wu J, Wang T, Li Y, Chen J (2022) Transmission of multidrug-resistant Mycobacterium tuberculosis in Wuhan, China: A retrospective molecular epidemiological study. Medicine (Baltimore) 101:e28751

Article  CAS  PubMed  Google Scholar 

Jiang Q, Liu Q, Ji L, Li J, Zeng Y, Meng L, Luo G, Yang C, Takiff HE, Yang Z, Tan W, Yu W, Gao Q (2020) Citywide transmission of multidrug-resistant tuberculosis under China’s rapid urbanization: a retrospective population-based genomic spatial epidemiological study. Clin Infect Dis 71:142–151

Article  PubMed  Google Scholar 

Zhang YN, Chen Y, Wang Y et al (2020) Reduction in healthcare services during the COVID-19 pandemic in China. BMJ Glob Health 5(11):e003421. https://doi.org/10.1136/bmjgh-2020-003421

Drain PK, Bajema KL, Dowdy D et al (2018) Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection. Clin Microbiol Rev 31(4):e00021-18. https://doi.org/10.1128/CMR.00021-18

Tang P, Liang E, Zhang X, Feng Y, Song H, Xu J, Wu M, Pang Y (2021) Prevalence and risk factors of subclinical tuberculosis in a low-incidence setting in China. Front Microbiol 12:731532

Article  PubMed  Google Scholar 

Onozaki I, Law I, Sismanidis C, Zignol M, Glaziou P, Floyd K (2015) National tuberculosis prevalence surveys in Asia, 1990–2012: an overview of results and lessons learned. Trop Med Int Health 20:1128–1145

Article  PubMed  Google Scholar 

Kendall EA, Shrestha S, Dowdy DW (2021) The epidemiological importance of subclinical tuberculosis. A critical reappraisal. Am J Respir Crit Care Med 203:168–174

Article  PubMed  PubMed Central  Google Scholar 

Huo F, Ma Y, Liu R et al (2020) Interpretation of discordant rifampicin susceptibility test results obtained using GeneXpert vs phenotypic drug susceptibility testing. Open Forum Infect Dis 7(8):ofaa279. https://doi.org/10.1093/ofid/ofaa279

Guo J, Liu R, Shi J, Huo F, Shang Y, Wang F, Gao M, Li S (2021) Rarity of rpoB Mutations outside the rifampicin resistance-determining region of mycobacterium tuberculosis isolates from patients responding poorly to first-line tuberculosis regimens in Beijing, China: A Retrospective Study. Infect Drug Resist 14:2607–2612

Article  PubMed  PubMed Central  Google Scholar 

Wang W, Liu R, Yao C, Huo F, Shang Y, Zhang X, Wang Y, Xue Z, Ma L, Pang Y (2022) Reevaluating rifampicin breakpoint concentrations for mycobacterium tuberculosis isolates with disputed rpoB mutations and discordant susceptibility phenotypes. Microbiol Spectr 10:e0208721

Article  PubMed  Google Scholar